Thank you for your request for information about the following:

How many applications for the VITT complication of the AstraZeneca vaccine have been made to the Vaccine Damage Payment Scheme?

How many were successful?

Of the unsuccessful ones, what was the reason for rejecting the applications

a) Diagnosis was not VITT

b) Applicant was not 60% or more disabled

c) A combination of the above

d) Other

Your request was received on 19/04/2023 and I am dealing with it under the terms of the Freedom of Information Act 2000.

Response

Question 1

As of 28 April 2023, a total of 62 applications have been independently assessed under the Vaccine Damage Payment Scheme, in relation to VITT following an AstraZeneca vaccine against COVID-19 (coronavirus).

It is not possible to conclusively state whether a claim relates to a specific condition until it has been reviewed by the independent medical assessor. Therefore, we do not hold full data on the total number of claims received relating to VITT following an AstraZeneca vaccine against COVID-19 (coronavirus).

Question 2

Of this number, 39 have been successful.

Question 3

a) No claims were unsuccessful due to the diagnosis not being VITT.

b) 16 were unsuccessful due to the claimant being assessed by the independent medical assessor as less than 60% disabled.

c) No claims were unsuccessful due to a combination of these factors.

d) 7 claims were unsuccessful because of causation due to the vaccine not being accepted by the independent medical assessor.

Data Queries

If you have any queries regarding the data provided, or if you plan on publishing the data please contact nhsbsa.foirequests@nhs.net ensuring you quote the above reference. This is important to ensure that the figures are not misunderstood or misrepresented.

If you plan on producing a press or broadcast story based upon the data please contact nhsbsa.communicationsteam@nhs.net. This is important to ensure that the figures are not misunderstood or misrepresented.

The information supplied to you continues to be protected by the Copyright, Designs and Patents Act 1988 and is subject to NHSBSA copyright. This information is licenced under the terms of the Open Government Licence detailed at: http://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/

Should you wish to re-use the information you must include the following statement: “NHSBSA Copyright 2023” This information is licenced under the terms of the Open Government Licence:

http://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/

Failure to do so is a breach of the terms of the licence.

Information you receive which is not subject to NHSBSA Copyright continues to be protected by the copyright of the person, or organisation, from which the information originated. Please obtain their permission before reproducing any third party (non NHSBSA Copyright) information.